Form 8-K - Current report:
SEC Accession No. 0001564590-19-014817
Filing Date
2019-05-01
Accepted
2019-05-01 16:10:24
Documents
2
Period of Report
2019-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-8k_20190331.htm 8-K 32841
2 EX-99.1 acad-ex991_6.htm EX-99.1 209649
  Complete submission text file 0001564590-19-014817.txt   243639
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 19787572
SIC: 2834 Pharmaceutical Preparations